By Ria Kakkad (Drug Target Review)2023-01-04T11:19:38
Combining AI with cutting-edge flow cytometry and massive sequencing technologies, researchers describe CAR T cell characteristics that determine their therapeutic capacity for the first time.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-26T13:58:00Z
2023-09-27T13:56:39
Sponsored by Euretos
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2023-03-28T11:38:32
Sponsored by Bio-Techne
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-11-24T12:06:45
Sponsored by Quantum-Si
Site powered by Webvision Cloud